Corbus Pharmaceuticals Holdings (CRBP) Short-term Investments (2020 - 2025)

Corbus Pharmaceuticals Holdings' Short-term Investments history runs 6 years deep, the most recent figure standing at $670000.0 for Q4 2025.

• In Q4 2025, Short-term Investments fell 99.49% year-over-year to $670000.0; the TTM figure through Dec 2025 stood at $670000.0 (down 99.49% YoY), while the FY2025 annual figure was $670000.0, down 99.49% from the prior year.
• Short-term Investments was $670000.0 for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $285000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $131.9 million in Q4 2024 to a low of $192000.0 in Q4 2023.
• Historically, Short-term Investments has averaged $34.1 million across 5 years, with a median of $9.1 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments plunged 99.74% in 2022, then jumped 68579.17% in 2024.
• A 5-year view of Short-term Investments shows it stood at $72.6 million in 2021, then slumped by 99.74% to $192475.0 in 2022, then slipped by 0.25% to $192000.0 in 2023, then surged by 68579.17% to $131.9 million in 2024, then slumped by 99.49% to $670000.0 in 2025.
• The last three Short-term Investments figures came in at $670000.0 (Q4 2025), $285000.0 (Q3 2025), and $96.5 million (Q2 2025), per Business Quant data.